Navigation Links
C. therm. Polymerase One-Step RT-PCR System

for one-step RT-PCR amplification of up to 3 kb RNA targets Cat. No. 2 016 338 50 reactions
Cat. No. 2 016 346 250 reactions Description The system contains a unique enzyme blend of C. therm. Polymerase and Taq DNA Polymerase.

Note: C. therm. Polymerase provided by Roche Applied Science is the recombinant form of the DNA polymerase from the thermophilic eubacterium Carboxydothermus hydrogenoformans, expressed in E. coli. The recombinant enzyme lacks the 5'3' exonuclease domain (RNase H activity) of the native enzyme. The system also contains RT-PCR reaction buffer (5x conc.) with 12.5 mM MgCl2 and 10% DMSO; DMSO solution; and 100 mM DTT solution. Application The C. therm. Polymerase One-Step RT-PCR System may be used for a one-tube, one-step RT-PCR. The C. hydrogenoformans DNA polymerase produces first strand cDNA with high yield and specificity, then Taq DNA Polymerase amplifies the cDNA. The system may be used for:
  • Amplification of up to 3 kb targets (especially GC-rich sequences) from mRNA or total RNA for virus detection, cloning, mutation analysis, etc.
  • Qualitative, semi-quantitative, or quantitative analysis of RNA transcription levels (in combination with gel-based or ELISA detection methods).
  • RT-PCR in the presence of dUTP for prevention of carry-over contamination in combination with UNG (see the pack insert for details).
Application profile Operating paramet ers
  • Sample: 50 pg to 5 g total RNA.
  • Temperature optimum, reverse transcriptase reaction: 5072C.
  • Divalent ion requirement: Mg2+.
  • Works with UNG (RT-PCR carry-over prevention).
  • Accepts DIG-labeled and other modified nucleotides.
Experimental result Comparison of C. therm Polymerase, Supplier Ls RNase H - Reverse Transcriptase, and Supplier Ps AMV Reverse Transcriptase for RT-PCR. Template: Total RNA isolated from K562 cell line. Primer: TGF-beta. Target: 650 bp product. 1.5 M betaine to dissolve secondary structure. Positive Controls: 1 ng of a 997 bp beta-actin fragment from mouse. Lane 1: C. therm. polymerase/Taq for 30 min at 60C. Lane 2: Superscript II/Taq for 50 min at 42C. Lane 3: AMV(Promega)/Taq for 60 min at 42C. Result: C. therm works on templates where other systems fail. Key advantages
  • Extends the sensitivity of RT-PCR, because the system can detect as few as 100 copies of a template (e.g. viral RNA).
  • Ensures high specificity amplification, because the system will accurately amplify target RNA even in the presence of large amounts of non-specific RNA.
  • Efficiently transcribes GC-rich RNA regions, due to the high temperature of the cDNA reaction and the presence of DMSO in the reaction buffer.
  • Ensures high fidelity RT-PCR, because the C. therm. Polymerase One-Step RT-PCR System has a twofold lower transcriptional error rate than Tth DNA Polymerase.
  • Permits UNG-mediated carry-over prevention, because the system will incorporate dUTP into amplified products that can then be removed by UNG in a subsequent PCR.


'"/>

Source:


Page: All 1 2 3

Related biology technology :

1. C. therm. Polymerase for Reverse Transcription in Two-Step RT-PCR
2. Novel PCR Enhancing Factor Improves Performance of Pfu DNA Polymerase
3. Pfu DNA Polymerase as a Hot Start Alternative
4. PCR Performance Comparisons Between pfuturbo and Taq DNA Polymerases
5. pfuturbo DNA Polymerase: A High-Performance, High-Fidelity Enzyme Ideal for PCR Cloning
6. Unique DNA Polymerase Formulation Excels in a Broad Range of PCR Applications
7. Enhanced Amplification of Long Targets with PfuTurbo DNA Polymerase
8. High-Fidelity PCR with a Novel Polymerase Mixture
9. Optimizing pfuturbo DNA Polymerase Amplification Reactions with Perfect Match PCR Enhancer
10. Unique Enhanced DNA Polymerase Delivers High Fidelity and Great PCR Performance
11. The Use of MasterTaq Polymerase for PCR with Humic Material-Contaminated DNA
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/4/2016)... LEXINGTON, Massachusetts , February 4, 2016 - New ... --> - New FDA action date of July ... date of July 22, 2016   - ... the U.S. in the past decade indicated for the treatment of signs and ... Lifitegrast has the potential to be the only product approved in the ...
(Date:2/4/2016)... 4, 2016  CytoSorbents Corporation (NASDAQ: CTSO ... flagship CytoSorb® blood filter to treat deadly inflammation ... world, announced that CEO Dr. Phillip Chan ... Capital Group,s 2016 Disruptive Growth & Healthcare Conference, ... Conference Presentation Details: Where: Convene ...
(Date:2/4/2016)... Feb. 4, 2016 Sinovac Biotech Ltd. ("Sinovac" ... provider of biopharmaceutical products in China ... board of directors received on February 4, 2016 a ... a consortium comprised of PKU V-Ming ( Shanghai ... Ltd., CICC Qianhai Development ( Shenzhen ) ...
(Date:2/3/2016)... 2016  Discovery Laboratories, Inc. (NASDAQ: DSCO ... KL4 surfactant therapies for respiratory diseases, today announced ... inducement award as a component of employment compensation ... President and Chief Executive Officer.  The award was ... 1, 2016 and granted as an inducement material ...
Breaking Biology Technology:
(Date:2/3/2016)... , February 3, 2016 ... market research report "Automated Fingerprint Identification System Market by ... Search), Application (Banking & Finance, Government, Healthcare, and Transportation) ... MarketsandMarkets, the market is expected to be worth USD ... 21.0% between 2015 and 2020. The transformation and technology ...
(Date:2/2/2016)... 2016  BioMEMS devices deployed in hospitals ... medical screening and diagnostic applications, such as ... that facilitate and assure continuous monitoring without ... being bolstered through new opportunities offered by ... coupled with wireless connectivity and low power ...
(Date:2/2/2016)... YORK , Feb. 2, 2016 Technology Enhancements ... presents an analysis of the digital and computed radiography ... Malaysia , and Indonesia ... trends and market size, as well as regional market ... country and discusses market penetration and market attractiveness, both ...
Breaking Biology News(10 mins):